Advanzeon Solutions, Inc. (CHCR)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Advanzeon Solutions, Inc. (CHCR) with AI Score 46/100 (Weak). Advanzeon Solutions, Inc. , operating through its subsidiary, focuses on administering and operating the SleepMaster Solutions sleep apnea program. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Advanzeon Solutions, Inc. (CHCR) Healthcare & Pipeline Overview
Advanzeon Solutions, Inc. operates in the healthcare sector, focusing on sleep apnea program administration through its SleepMaster Solutions. Currently trading on the OTC market after a Chapter 11 filing, the company faces challenges in a competitive medical care facilities landscape.
Investment Thesis
Investing in Advanzeon Solutions, Inc. (CHCR) presents significant risks due to its OTC market listing and recent Chapter 11 bankruptcy filing in 2020. The company's reliance on the SleepMaster Solutions program for revenue makes it vulnerable to market shifts and competition. With a market capitalization of $0.00B and a beta of 1.24, CHCR exhibits high volatility. Potential investors should closely monitor the company's restructuring efforts and ability to regain financial stability. Growth catalysts are uncertain, and the company's future depends on successfully navigating its bankruptcy proceedings and re-establishing a competitive position in the healthcare sector.
Based on FMP financials and quantitative analysis
Key Highlights
- Advanzeon Solutions, Inc. operates the SleepMaster Solutions sleep apnea program.
- The company filed for Chapter 11 bankruptcy on September 7, 2020.
- CHCR trades on the OTC market, indicating higher risk and lower liquidity.
- The company's market capitalization is $0.00B, reflecting its distressed financial state.
- The company's beta is 1.24, indicating higher volatility than the market.
Competitors & Peers
Strengths
- Specialized SleepMaster Solutions program.
- Experience in sleep apnea program administration.
- Established presence in the healthcare sector.
- Focus on a specific medical condition.
Weaknesses
- Recent Chapter 11 bankruptcy filing.
- OTC market listing indicating higher risk.
- Limited market capitalization.
- Reliance on a single product line.
Catalysts
- Upcoming: Successful restructuring and emergence from Chapter 11 bankruptcy could restore investor confidence.
- Ongoing: Expansion of the SleepMaster Solutions program into new markets could drive revenue growth.
- Ongoing: Strategic partnerships with healthcare providers could enhance market penetration.
Risks
- Ongoing: Financial instability due to Chapter 11 bankruptcy.
- Potential: Intense competition in the medical care facilities industry.
- Potential: Regulatory changes and reimbursement pressures.
- Ongoing: Limited liquidity and high volatility due to OTC market listing.
- Potential: Dependence on a single product line (SleepMaster Solutions).
Growth Opportunities
- Expansion of Sleep Apnea Program: Advanzeon could focus on expanding its SleepMaster Solutions program by targeting new geographic markets and patient demographics. The global sleep apnea devices market is projected to reach $5.2 billion by 2027, offering a substantial growth opportunity. Success depends on effective marketing, strategic partnerships, and demonstrating superior patient outcomes.
- Telehealth Integration: Integrating telehealth services into the SleepMaster Solutions program could enhance accessibility and convenience for patients, particularly in remote areas. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing demand for remote healthcare solutions. This integration could improve patient engagement and reduce operational costs.
- Strategic Partnerships: Forming strategic alliances with healthcare providers, insurance companies, and sleep clinics could expand Advanzeon's reach and market penetration. Partnerships can provide access to new patient referrals, distribution channels, and reimbursement opportunities. Successful partnerships require alignment of goals, clear communication, and mutual benefit.
- Product Diversification: Diversifying beyond sleep apnea treatment into related respiratory care services could broaden Advanzeon's revenue streams and reduce its reliance on a single product line. This could include offering diagnostic services, respiratory therapy, and home healthcare solutions. Diversification requires careful market research, investment in new technologies, and skilled personnel.
- Cost Optimization: Implementing cost-saving measures and streamlining operations could improve Advanzeon's financial performance and enhance its competitiveness. This includes optimizing supply chain management, reducing administrative expenses, and improving operational efficiency. Cost optimization is crucial for companies facing financial challenges and can improve profitability and cash flow.
Opportunities
- Expansion into new geographic markets.
- Integration of telehealth services.
- Strategic partnerships with healthcare providers.
- Diversification into related respiratory care services.
Threats
- Intense competition in the medical care facilities industry.
- Regulatory changes and reimbursement pressures.
- Potential for product obsolescence.
- Economic downturn affecting patient affordability.
Competitive Advantages
- Proprietary SleepMaster Solutions program.
- Established relationships with healthcare providers.
- Experience in sleep apnea program administration.
- Focus on specialized care services.
About CHCR
Advanzeon Solutions, Inc., formerly known as Comprehensive Care Corporation, was established in 1969 and rebranded in January 2014. Headquartered in Tampa, Florida, the company operates through its subsidiary, Pharmacy Value Management Solutions, Inc., which administers and manages the SleepMaster Solutions program, a sleep apnea treatment service. Advanzeon's core business revolves around providing solutions for individuals suffering from sleep apnea, a prevalent condition affecting millions. However, on September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, impacting its operational and financial stability. The company's long-term viability hinges on its ability to restructure and regain market confidence while navigating the competitive landscape of the medical care facilities industry.
What They Do
- Administers and operates the SleepMaster Solutions sleep apnea program.
- Provides solutions for individuals suffering from sleep apnea.
- Operates through its subsidiary, Pharmacy Value Management Solutions, Inc.
- Offers sleep apnea treatment services.
- Focuses on managing sleep apnea programs.
- Aims to improve the quality of life for sleep apnea patients.
Business Model
- Generates revenue through the SleepMaster Solutions program.
- Provides sleep apnea treatment services to patients.
- Partners with healthcare providers and insurance companies.
- Focuses on program administration and management.
Industry Context
Advanzeon Solutions, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized care services, including sleep apnea treatment. However, the competitive landscape is intense, with established players and emerging technologies vying for market share. Advanzeon's position is challenged by its recent bankruptcy filing and the need to restructure its operations. The industry is also subject to regulatory changes and reimbursement pressures, further impacting the company's prospects.
Key Customers
- Individuals suffering from sleep apnea.
- Healthcare providers and sleep clinics.
- Insurance companies covering sleep apnea treatment.
- Patients seeking solutions for sleep-related breathing disorders.
Financials
Chart & Info
Advanzeon Solutions, Inc. (CHCR) stock price: Price data unavailable
Latest News
No recent news available for CHCR.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHCR.
Price Targets
Wall Street price target analysis for CHCR.
MoonshotScore
What does this score mean?
The MoonshotScore rates CHCR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Clark A. Marcus
Managing Director
Clark A. Marcus serves as the Managing Director of Advanzeon Solutions, Inc. His role involves overseeing the company's operations and strategic direction. Information on his prior experience and education is not available. As the managing director, he is responsible for the overall performance and management of the company, particularly during its restructuring phase following the Chapter 11 filing.
Track Record: Due to limited information available, Clark A. Marcus's specific achievements and strategic decisions at Advanzeon Solutions, Inc. are unknown. His tenure is marked by the company's Chapter 11 bankruptcy filing in 2020, indicating significant challenges during his leadership. Evaluating his long-term impact requires further information on the company's restructuring efforts and future performance.
CHCR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Advanzeon Solutions, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may be undergoing financial distress or restructuring. Unlike NYSE or NASDAQ-listed companies, OTC Other stocks generally have less stringent listing requirements, leading to increased risk and volatility for investors. This tier signifies a higher level of caution is warranted due to the potential for limited information and regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other listing.
- High price volatility and potential for manipulation.
- Risk of delisting or trading suspension.
- Limited liquidity and wide bid-ask spreads.
- Potential for fraud or mismanagement.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Analyze the company's debt and cash flow situation.
- Monitor news and press releases for updates on the company's restructuring efforts.
- Consult with a financial advisor before investing.
- Established history since 1969.
- Operation of the SleepMaster Solutions program.
- Presence in the healthcare sector.
- Continued efforts to restructure after bankruptcy.
- Existence of a subsidiary, Pharmacy Value Management Solutions, Inc.
Common Questions About CHCR
What does Advanzeon Solutions, Inc. do?
Advanzeon Solutions, Inc., through its subsidiary Pharmacy Value Management Solutions, Inc., administers and operates the SleepMaster Solutions program, which provides sleep apnea treatment services. The company focuses on managing sleep apnea programs and offering solutions to individuals suffering from sleep-related breathing disorders. Despite its long history, Advanzeon filed for Chapter 11 bankruptcy in 2020 and currently trades on the OTC market, reflecting its distressed financial condition and challenging business environment.
What do analysts say about CHCR stock?
Given Advanzeon Solutions, Inc.'s OTC listing and recent bankruptcy filing, formal analyst coverage is unlikely. Key valuation metrics are difficult to assess due to the company's financial instability. Growth considerations are highly speculative, contingent on successful restructuring and market recovery. Investors should conduct thorough due diligence and consider the significant risks associated with this stock. There is no consensus or recommendation available from analysts.
What are the main risks for CHCR?
The main risks for Advanzeon Solutions, Inc. include its ongoing Chapter 11 bankruptcy proceedings, which create uncertainty about its future viability. Its OTC market listing indicates higher risk and lower liquidity. The company's reliance on the SleepMaster Solutions program makes it vulnerable to competition and market shifts. Additionally, regulatory changes and reimbursement pressures in the healthcare sector could negatively impact its financial performance. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for CHCR?
Advanzeon Solutions, Inc. (CHCR) currently holds an AI score of 46/100, indicating low score. Key strength: Specialized SleepMaster Solutions program.. Primary risk to monitor: Ongoing: Financial instability due to Chapter 11 bankruptcy.. This is not financial advice.
How frequently does CHCR data refresh on this page?
CHCR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CHCR's recent stock price performance?
Recent price movement in Advanzeon Solutions, Inc. (CHCR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized SleepMaster Solutions program.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CHCR overvalued or undervalued right now?
Determining whether Advanzeon Solutions, Inc. (CHCR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CHCR?
Before investing in Advanzeon Solutions, Inc. (CHCR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and bankruptcy filing.
- Financial data may not be readily available or reliable.
- Analyst coverage is unlikely given the company's financial condition.